Hercules Capital Inc HTGC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HTGC is a good fit for your portfolio.
News
-
Hercules Capital Announces Date of 2024 Annual Meeting of Stockholders
-
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
-
X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility
-
Hercules Capital Announces Upcoming Event for the Financial Community
-
Hercules Capital Reports First Quarter 2024 Financial Results
-
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024
-
Hercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative Originations
-
Hercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference Call
Trading Information
- Previous Close Price
- $21.18
- Day Range
- $21.17–21.38
- 52-Week Range
- $14.62–21.38
- Bid/Ask
- $21.16 / $21.30
- Market Cap
- $3.44 Bil
- Volume/Avg
- 1.0 Mil / 858,910
Key Statistics
- Price/Earnings (Normalized)
- 10.84
- Price/Sales
- 6.45
- Dividend Yield (Trailing)
- 9.05%
- Dividend Yield (Forward)
- 9.05%
- Total Yield
- 9.05%
Company Profile
Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
- Sector
- Financial Services
- Industry
- Asset Management
- Stock Style Box
- Small Value
- Total Number of Employees
- 100
- Website
- https://www.htgc.com
Comparables
Valuation
Metric
|
HTGC
|
HRZN
|
RWAY
|
---|---|---|---|
Price/Earnings (Normalized) | 10.84 | — | 9.68 |
Price/Book Value | 1.83 | 1.25 | 0.88 |
Price/Sales | 6.45 | 10.58 | 3.63 |
Price/Cash Flow | — | — | 2.47 |
Price/Earnings
HTGC
HRZN
RWAY
Financial Strength
Metric
|
HTGC
|
HRZN
|
RWAY
|
---|---|---|---|
Quick Ratio | — | — | — |
Current Ratio | — | — | — |
Interest Coverage | — | — | — |
Quick Ratio
No chart available
Profitability
Metric
|
HTGC
|
HRZN
|
RWAY
|
---|---|---|---|
Return on Assets (Normalized) | 9.86% | −1.74% | 4.07% |
Return on Equity (Normalized) | 19.81% | −4.12% | 7.96% |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
HTGC
HRZN
RWAY
Asset Management Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
BlackRock Inc
BLK
| Hrplrbghxg | Lmpq | $117.5 Bil | |||
KKR & Co Inc Ordinary Shares
KKR
| Ylhydlh | Dyhjy | $94.1 Bil | |||
Blackstone Inc
BX
| Jdtygtxx | Qpsrtkf | $92.2 Bil | |||
Bank of New York Mellon Corp
BK
| Mlhdwbp | Kdcct | $44.8 Bil | |||
Ameriprise Financial Inc
AMP
| Ctpbnqyw | Rphbshf | $42.9 Bil | |||
T. Rowe Price Group Inc
TROW
| Gpxjntgc | Llmh | $25.6 Bil | |||
State Street Corporation
STT
| Pcsqhldd | Xwfx | $22.2 Bil | |||
Northern Trust Corp
NTRS
| Jzrjjnzm | Zwd | $17.0 Bil | |||
The Carlyle Group Inc
CG
| Vzxmzxwv | Qsbqvq | $14.5 Bil | |||
Franklin Resources Inc
BEN
| Gyyqfpxr | Gmrvp | $11.6 Bil |